US FDA staff flags concerns on MDMA-assisted PTSD treatment
(Reuters) -The U.S. health regulator's staff reviewers on Friday raised concerns related to interpretation of results from tr...
May 31, 2024
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
By Michael Erman (Reuters) - Pfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
May 31, 2024
Gilead's Trodelvy extends lung cancer survival by just 1.3 months in trial
By Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than chemotherapy in previously t...
May 31, 2024
Novartis leukemia drug more effective than older treatments in trial
By Christy Santhosh (Reuters) - Swiss drugmaker Novartis said patients with a type of leukemia who took its Scemblix had a si...
May 31, 2024
EU regulator recommends use of Pfizer's gene therapy for rare bleeding disorder
(Reuters) - The European Medicines Agency has recommended the use of Pfizer's gene therapy for a rare bleeding disorder calle...
May 31, 2024
EU regulator recommends use of Valneva's chikungunya vaccine
(Reuters) - The European Medicines Agency (EMA) recommended the use of Valneva's single-shot vaccine for chikungunya virus, t...
May 31, 2024
World unprepared for another pandemic as WHO treaty talks push on
By Emma Farge and Jennifer Rigby LONDON (Reuters) - The world is unprepared for another health crisis like COVID-19, a leadin...
May 31, 2024
FDA extends deadline, requests more data on Sanofi's Dupixent for treating 'smoker's lung'
(Reuters) - French drugmaker Sanofi and its partner Regeneron said on Friday the U.S. Food and Drug Administration (FDA) requ...
May 31, 2024
European Commission grants marketing approval to Biogen's ALS drug
(Reuters) -Biogen said on Thursday that the European Commission has granted marketing authorization under exceptional circums...
May 30, 2024
Gilead's Trodelvy fails to meet main goal in late-stage study
(Reuters) - Gilead Sciences said on Thursday its drug Trodelvy, tested in patients with bladder cancer who previously receive...
May 30, 2024